Executive Medical Director, Multiple Myeloma Lead

Lead the clinical development strategy for a novel Multiple Myeloma pipeline, from first-in-human studies through proof-of-concept and toward potential registration.

Our client is a global biotechnology company dedicated to treating and one day curing life-threatening diseases. The company is advancing the next generation of cell therapy (CAR-T) through innovative platforms.

Our client is seeking an Executive Medical Director, Clinical Development to serve as the clinical lead for its Multiple Myeloma pipeline within the Clinical Development organization. This individual will provide strategic, scientific, and medical leadership for the pipeline, accountable for shaping the myeloma strategy and executing an integrated clinical development plan across a portfolio of assets spanning early-stage and, as appropriate, later-stage development. The role spans first-in-human, dose-escalation, dose-expansion, and proof-of-concept studies, supporting IND submissions and regulatory interactions while integrating translational, biomarker, pharmacology, and safety data.

Ultimately, this leader will drive the generation of high-quality clinical data to guide pipeline decisions and support benefit-risk assessment, differentiation, and potential registration. The successful candidate will bring deep multiple myeloma expertise, strong scientific judgment, and the ability to lead effectively in a fast-paced, highly matrixed environment.

Essential Duties and Responsibilities

This list represents the major duties of the role and is not all-inclusive. The successful candidate may be asked to perform related duties beyond those described here.

Pipeline & Clinical Strategy Leadership

• Serve as the clinical lead for the Multiple Myeloma pipeline, providing strategic, scientific, and medical leadership across the development lifecycle.
• Develop and execute the integrated clinical development plan, including disease setting and line of therapy, patient population selection, endpoint strategy, dose-selection rationale, combination strategy, biomarker and measurable residual disease (MRD) strategy, safety monitoring approach, and evidence-generation plan.
• Drive pipeline prioritization, asset sequencing, and stage-gate decisions, setting data-driven criteria for advancing, pausing, or terminating assets.
• Identify opportunities to differentiate and expand the pipeline through novel targets, treatment modalities, combinations, and sequencing, and contribute clinical expertise to business development and due diligence activities.
• Represent the pipeline in internal governance forums, senior leadership reviews, external scientific meetings, regulatory interactions, and partnership discussions as needed.

Study Design & Execution

• Lead the design, execution, monitoring, interpretation, and reporting of first-in-human, dose-escalation, dose-expansion, proof-of-concept, and other early clinical studies in multiple myeloma.
• Lead or contribute to late-stage clinical development activities when appropriate, including pivotal study strategy, comparator and endpoint selection, protocol design, data interpretation, and registration-enabling planning.
• Provide medical and scientific oversight for study conduct, including medical monitoring, eligibility review, safety review, dose-escalation decision-making, and interpretation of emerging clinical data.
• Ensure early development plans reflect contemporary regulatory expectations for oncology drug development, including robust dose optimization, PK/PD integration, biomarker-informed decision-making, and clear benefit-risk assessment.

Regulatory & Scientific Deliverables

• Provide clinical leadership for protocols, clinical study reports, investigator brochures, regulatory briefing documents, IND submissions, health authority meeting packages, publications, abstracts, and presentations.
• Identify key pipeline risks and mitigation strategies, including clinical, regulatory, operational, safety, competitive, and translational risks.

Cross-Functional & External Collaboration

• Partner closely with translational science, biomarker, pharmacology, nonclinical, regulatory, safety and pharmacovigilance, biostatistics, data management, clinical operations, project management, CMC, business development, and commercial colleagues to ensure integrated and executable development plans.
• Engage with investigators, academic experts, cooperative groups, study sites, patient advocacy organizations, and external advisors to support high-quality execution, scientific exchange, enrollment strategy, and visibility in the myeloma community.

Team Leadership

• Provide leadership and supervision to clinical development medical directors and clinical science staff supporting the pipeline.
• Champion a culture of patient focus, scientific rigor, collaboration, urgency, ethics, compliance, and operational excellence.

Qualifications

The requirements below are representative of the knowledge, skills, and abilities needed to perform this role successfully.

Required

• MD, MD-PhD, or equivalent medical degree; board certification in hematology or oncology.
• Minimum of 6 years of clinical development experience in the biopharmaceutical industry and/or academic medicine, with substantial experience in hematologic malignancies and multiple myeloma.
• Demonstrated experience designing and leading early clinical development programs, including first-in-human studies, dose escalation, dose expansion, dose selection, integrated safety monitoring, clinical data review, and proof-of-concept generation.
• Strong understanding of multiple myeloma clinical development, including IMWG response criteria, measurable residual disease, safety monitoring, benefit-risk evaluation, dose optimization, biomarker strategy, and clinical development decision-making.
• Ability to translate complex medical, scientific, translational, regulatory, and competitive information into clear clinical development strategies and actionable plans.
• Excellent written and verbal communication skills, including experience developing clinical and regulatory documents, presenting to senior leaders, and engaging external experts and investigators.
• Strong collaboration, influencing, conflict-management, negotiation, and decision-making skills, with the ability to align stakeholders across functions, geographies, and levels of the organization.
• Demonstrated ability to anticipate and integrate needs from clinical operations, regulatory, safety and pharmacovigilance, biometrics, translational science, project management, CMC, and other development functions.
• Track record of delivering results in a fast-paced environment, with the ability to operate strategically while contributing hands-on when needed.
• Commitment to the highest standards of quality, ethics, compliance, patient safety, and professional conduct.
• Ability to travel up to 15% to 20% of the time.

Preferred

• Multiple myeloma clinical development experience across relapsed/refractory and earlier-line settings.
• Experience with cell therapy, CAR-T, in vivo cell therapy, T-cell engagers, bispecific antibodies, antibody-drug conjugates, protein degraders, or other novel modalities for myeloma.
• Experience leading or contributing to pipelines with multiple assets, indications, or lifecycle opportunities, including pipeline governance, prioritization, and investment decisions.
• Experience contributing to IND submissions, pre-IND or IND meetings, regulatory briefing packages, and health authority interactions.
• Experience leading or significantly contributing to cross-functional development teams in a matrixed, global environment.

Engagement & Location

• Structure: Full-time, permanent, direct-hire position.
• Location: Hybrid, based in Central New Jersey.

Compensation: $350,000 - $405,000 base salary plus target annual bonus, long-term incentive (LTI) eligibility, and a new-hire equity grant.

The compensation offered will be commensurate with experience, skills, qualifications, and other relevant factors.

About the Search

This search is being managed by Summit Strategic Search on behalf of our client. This is a full-time, permanent position where the successful candidate will be hired directly by the end client.

Equal Opportunity Commitment: Summit Strategic Search and our client are equal opportunity partners. All qualified applicants will receive consideration for employment without regard to race, religion, color, national origin, gender, gender identity or expression, sexual orientation, age, marital status, veteran status, or disability status.

Accommodations & Support: We are committed to providing reasonable accommodations for qualified individuals with disabilities during the application and interview process. If you require assistance, please contact us at admin@summitstrategicsearch.com. We maintain a zero-tolerance policy for harassment and provide all employees with dedicated reporting channels to ensure a safe, professional work environment.

Selection & Onboarding: As this is a direct-hire role within a regulated industry, the end client's standard hiring protocols apply. This includes, but is not limited to, a comprehensive background check and drug screening prior to the start of employment. All hiring decisions are made solely by the end client.